Overview Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye Status: Completed Trial end date: 2009-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the safety and efficacy of RX-10045 to placebo for the treatment of the signs and symptoms of dry eye. Phase: Phase 2 Details Lead Sponsor: Resolvyx Pharmaceuticals, Inc